The findings position Intellia to bring to market the first “in vivo” gene editing medicine, though the therapy’s commercial ...
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.
A research university emphasizes entrepreneurial science—and spawns start-ups in fields as varied as genetic medicine, ...
Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...
Most asset managers try to track the market. Through ARK Investment, Cathie Wood is trying to get ahead of the market’s best ...
Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...
Using CRISPR, multiomics, and machine learning, molecular biologist Larschan unravels the mysteries of the X chromosome.
Genome‑wide CRISPR screens in primary human T cells reveal human genes that promote or block HIV infection, uncovering potent ...
A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results